What role can next-generation sequencing play in myelodysplastic syndrome care?

Expert Rev Hematol. 2019 Jun;12(6):379-382. doi: 10.1080/17474086.2019.1613151. Epub 2019 May 7.

Authors

Nicolas Bonadies^{1

2}, Vera Ulrike Bacher²

Affiliations

¹ a Department for BioMedical Research , University of Bern , Bern , Switzerland.
² b Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital , University of Bern , Bern , Switzerland.

PMID: 31063400
DOI: 10.1080/17474086.2019.1613151

No abstract available

Keywords: Myelodysplastic syndromes; clinical management; diagnosis; next generation sequencing; risk-stratification; targeted therapies.

Publication types

Editorial

MeSH terms

High-Throughput Nucleotide Sequencing / methods*
Humans
Myelodysplastic Syndromes / genetics*